Brookfield Corp’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-180,000
Closed -$18.5M 571
2023
Q2
$18.5M Sell
180,000
-20,000
-10% -$2.06M 0.07% 98
2023
Q1
$21.8M Buy
200,000
+117,500
+142% +$12.8M 0.08% 94
2022
Q4
$9.39M Sell
82,500
-3,473
-4% -$395K 0.04% 155
2022
Q3
$5.32M Buy
85,973
+21,283
+33% +$1.32M 0.02% 266
2022
Q2
$5.16M Sell
64,690
-51,494
-44% -$4.11M 0.02% 242
2022
Q1
$12.2M Buy
116,184
+36,075
+45% +$3.8M 0.05% 128
2021
Q4
$8.63M Buy
80,109
+11,331
+16% +$1.22M 0.03% 135
2021
Q3
$7.53M Buy
+68,778
New +$7.53M 0.03% 169